For other modalities, some significant biomarkers recognized for HNSCC in recent studies, such as EGFR (31) and USP14 (32), were identified by the LGB-based models, and both EGFR and USP14 show negative influence on patients’ survival with larger values (Figure 6A). The gene discussed is USP14; the disease is head and neck squamous cell carcinoma.